PCV39 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL
May 1, 2009, 00:00
10.1016/S1098-3015(10)73801-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)73801-8/fulltext
Title :
PCV39 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73801-8&doi=10.1016/S1098-3015(10)73801-8
First page :
Section Title :
Open access? :
No
Section Order :
269